Is Blurred Vision Common with COVID-19?
Blurred vision is a relatively common ocular symptom in COVID-19 patients, occurring in approximately 7-24% of infected individuals, though it is not among the most frequent manifestations of the disease.
Prevalence and Frequency
Based on the most recent guideline evidence, COVID-19 typically causes mild, self-limited conjunctival symptoms rather than vision-threatening complications 1. However, research data reveals variable rates of blurred vision:
- 24.2% of COVID-19 positive patients reported blurred vision in a 2024 Chinese study (n=335) 2
- 7.5% reported blurred vision in a 2024 Saudi Arabian study (n=200) 3
- 12% experienced blurred vision as their most common complaint in a 2025 Pakistani study (n=50) 4
The wide range (7-24%) suggests blurred vision is moderately common but not universal, occurring in roughly 1 in 4 to 1 in 13 COVID-19 patients depending on the population studied.
Clinical Context and Mechanisms
Blurred vision typically develops early in the disease course, with 51% of patients developing eye symptoms after the onset of systemic COVID-19 symptoms 2. The symptom appears related to several mechanisms:
- Direct conjunctival inflammation with superficial keratitis 1
- Retinal microvascular complications including retinal vein/artery occlusion from COVID-19's prothrombotic state 5
- Neuro-visual dysfunction affecting eye teaming and movement functions 6
- Acute macular neuroretinopathy occurring 2-3 days after high fever 7
Important Clinical Considerations
The severity of blurred vision does not necessarily correlate with systemic disease severity 2. However, patients with diabetes mellitus showed a borderline significant association with blurred vision (75% vs 35%, p=0.051) 8.
Key Prognostic Points:
- Most cases are self-limited with good prognosis 1, 9
- Visual acuity typically remains ≥20/40 in 74% of affected eyes 7
- Symptoms usually disappear within 5-21 days of treatment 1
- No short-term complications on visual acuity in typical cases 1
Red Flags Requiring Urgent Evaluation:
- Sudden vision loss (suggests retinal vascular occlusion or optic neuropathy) 5
- Persistent symptoms beyond 3 weeks
- Associated with severe systemic disease 4
- Patients with pre-existing diabetes or hyperlipidemia 8
Clinical Recommendation
For patients reporting blurred vision with COVID-19, reassure them this is a relatively common symptom that typically resolves spontaneously. However, perform or arrange ophthalmologic evaluation if symptoms persist beyond 2-3 weeks, worsen progressively, or occur in patients with diabetes or cardiovascular risk factors, as these may indicate retinal microvascular complications requiring monitoring 5, 7.